{"DataElement":{"publicId":"7382376","version":"1","preferredName":"Kaposi Sarcoma Lesion Assessment Count","preferredDefinition":"Number of Kaposi sarcoma lesions.","longName":"NUMLES","context":"AMC","contextVersion":"1","DataElementConcept":{"publicId":"5917699","version":"1","preferredName":"Kaposi Sarcoma Lesion Assessment","preferredDefinition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS)._A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part._The final result of a determination of the value, significance, or extent of.","longName":"2639367v1.0:5917697v1.0","context":"CITN","contextVersion":"1","ObjectClass":{"publicId":"2639367","version":"1","preferredName":"Kaposi Sarcoma","preferredDefinition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin however, it may also occur internally.  It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).","longName":"C9087","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kaposi Sarcoma","conceptCode":"C9087","definition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"30BF3151-5EE1-1E4A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-18","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-05-18","modifiedBy":"ONEDATA","dateModified":"2007-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2674665","version":"1","preferredName":"Lesion Assessment","preferredDefinition":"(LEE-zhun) An area of abnormal tissue change.:The final result of a determination of the value, significance, or extent of.","longName":"C3824:C25367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25367","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"385E1A0D-752C-038B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-23","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-08-23","modifiedBy":"ONEDATA","dateModified":"2007-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55DF8B68-978B-638D-E053-F662850A7048","latestVersionIndicator":"Yes","beginDate":"2017-08-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-08-03","modifiedBy":"SOKKERL","dateModified":"2017-08-07","changeDescription":"8/3/17 LS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7382375","version":"1","preferredName":"Lesion Count","preferredDefinition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part._Determining the number or amount of something.","longName":"7382375v1.0","context":"AMC","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3755216","version":"1","preferredName":"Lesion Count","preferredDefinition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.:To determine the number or amount of something; the result of this activity.","longName":"C3824:C25463","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Count","conceptCode":"C25463","definition":"Determining the number or amount of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC38EECE-7BC8-E7DD-E040-BB89AD4307AF","latestVersionIndicator":"Yes","beginDate":"2013-05-08","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-05-08","modifiedBy":"ONEDATA","dateModified":"2013-05-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AC49E364-06C6-0711-E053-4EBD850A5CEF","latestVersionIndicator":"Yes","beginDate":"2020-08-07","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-08-07","modifiedBy":"COLLIED","dateModified":"2020-08-25","changeDescription":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"7283431","version":"1","longName":"CRF CDEs","context":"AMC","ClassificationSchemeItems":[{"publicId":"7312662","version":"1","longName":"KS","context":"AMC"}]}],"AlternateNames":[{"name":"TRORRES_TOTAL2","type":"OID, AMC","context":"AMC"},{"name":"AMC","type":"USED_BY","context":"AMC"},{"name":"TRORRES_TOTAL1","type":"OID, AMC","context":"AMC"},{"name":"TRORRES_TOTAL3","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"Specify number of lesions","type":"Preferred Question Text","description":"Specify number of lesions","url":null,"context":"AMC"},{"name":"AMC Question Text 2","type":"Alternate Question Text","description":"Total Number of Lesions","url":null,"context":"AMC"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AC49F47C-7993-0715-E053-4EBD850A259D","latestVersionIndicator":"Yes","beginDate":"2020-08-07","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-08-07","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeDescription":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}